Biotechnology Industry Research Assistance Council (BIRAC)

Revisiting 2024's Landmark Moments in Biotech- Nafithromycin, a significant advancement in India's pharmaceutical innovation. #BIRAC #2024Review #BioE3Policy #Milestones

The last date to submit the proposals under the National Biopharma Mission ,BIRAC for eligible organizations to conduct training on Clinical Trials and ISO 13485:2018 has been extended to 7th January, 5:30 PM. Register now: https://lnkd.in/guCHKq-n Don't miss this opportunity

Reflecting on a year of innovation and growth..! Union Cabinet approved India’s first Policy in Biotechnology, the ‘BioE3 (Biotechnology for Economy, Environment and Employment) Policy for ‘Fostering High Performance Biomanufacturing’. This visionary initiative is designed to foster innovation, empower startups, and create a thriving biotech ecosystem in India. Along with prioritizing regenerative bioeconomy models of green growth, this policy will facilitate expansion of India’s skilled workforce and provide a surge in job creation. #BIRAC #2024Review #BioE3Policy #CabinetApprovals #Milestones #Sustainability #Startups #PolicyLeadership Rajesh Gokhale | Jitendra Kumar | Department of Biotechnology | Biotechnology Industry Research Assistance Council (BIRAC)

Unlock the Power of Innovation with the IP & Technology Management Law Clinic! Are you a budding entrepreneur, innovator, or startup looking to protect your intellectual property and scale your technology-driven ideas? Join us at the IP & Technology Management Law Clinic Connect, where the team will: 💡 Guide you through IP strategies tailored for startups 📜 Simplify the landscape of technology management 📈 Help you transform your ideas into scalable, sustainable ventures 📅 When: Second Friday of every month 🕒 Time: 4 PM to 6 PM 📍 Venue/Platform: Virtual To know more: https://lnkd.in/gP-qwaBN Let’s secure your innovation, strengthen your strategy, and shape the future of technology together! #BIRAC #Innovation #IPManagement #LawClinic #TechnologyManagement #Startups #Biotechnology #Entrepreneurship Vinita Jindal, PhD, RTTP, Registered Indian Patent Agent | Amit Katiyar | Varsha Padhi

The fourth session of the Webinar Series on "#Biomanufacturing and #Biofoundry Initiative" held on 27th December 2014, focused on: "Bio-manufacturing of Enzymes" The session continued to be a success with more than 466 participants in attendance from varied sectors. Dr. Vaishali Panjabi, Scientist 'F', DBT welcomed the participants and opened the session with introductory remarks. Dr. Alka Sharma, Senior Advisor and Scientist 'H', DBT, familiarized the audience with the BioE3 policy and spoke about how the policy promotes bio-manufacturing of enzymes in India and the efforts by DBT in this direction. Dr. Amit Yadav gave an overview of the field followed by a session by Dr. Syed Shams Yazdani, ICGEB, New Delhi, who gave insights into the development of novel host platforms through genome engineering for production of enzymes. Mr. G S Krishnan, President, ABLE spoke about the manufacturing roadmap for industrial enzymes, market penetration in India and how the policy encourages indigenous manufacturing. The session was followed by a Q&A session, moderated by Department of Biotechnology and Biotechnology Industry Research Assistance Council (BIRAC) officials, where attendees participated with queries related to manufacturing, implementation and opportunities for Indian manufacturers. Rajesh Gokhale | Jitendra Kumar | Dr. Alka Sharma | Dr. Vaishali Panjabi | Dr. Amit K Tripathi | Dr. Amit K. Yadav | Syed Shams Yazdani | Krishnan G S |sarma pakala | Dr. Sujit Das | Hemlata Chhabra | Smita Hingane

As nations mark International Day of Epidemic Preparedness on December 27, #MissionInd-CEPI a Joint program of Department of Biotechnology and Biotechnology Industry Research Assistance Council (BIRAC) is working towards India centric rapid vaccine development for Priority diseases through supporting the development of vaccines and platform technologies for infectious diseases of epidemic potential in India and Indian component of CEPI’s global efforts in pandemic preparedness. As a national program supported by Department of Biotechnology, Ind CEPI works in engagement with (CEPI (Coalition for Epidemic Preparedness Innovations) With the goal on the strengthening the existing innovative vaccine platform technologies within the country, the mission aims to support rapid outbreak response of vaccine development aligned with CEPI’s #100 days mission. “Strengthening India centric vaccine development for Priority diseases: Protecting India’s population from outbreaks. India's commitment towards Epidemic #Preparedness  Rajesh Gokhale | Jitendra Kumar | Dr chandra Madhavi | Shivangi Khanna NITI Aayog | Office of the Principal Scientific Adviser to the Government of India | World Health Organization | Gennova Biopharmaceuticals | Bharat Biotech #Publichealth #LMICS #100Days #ViksitBharat2047 #Vaccine #Pandemic #Epidemic #IndCepi #InfectiousDiseases #Priority #Pathogens #Global #India

We’ve expanded our horizons! BIRAC is now on Instagram! Stay connected for updates on biotech innovations, success stories, and all the exciting strides we’re making towards a better future. Follow us - dbt.birac

Dive into the transformative world of biotechnology with the 4th Webinar in the Biofoundry & Bio-manufacturing Initiative Series. Explore how enzymes are revolutionizing biomanufacturing processes. Don’t miss this opportunity to engage with industry leaders and experts. Let’s shape the future of biomanufacturing together! #Biofoundry #BioManufacturing #Webinar Time: 3 to 4 PM, Date- 27.12.2024 registration link: https://lnkd.in/g5pwX5WW (on first cum basis due to limited seats) Dr. Amit K. Yadav | Syed Shams Yazdani

From 50 to 9,000! 🚀 India's biotech revolution is rewriting the future with bold innovation and unstoppable determination. 🌟 Union Minister Jitendra Singh celebrates this incredible decade of growth, proving the limitless potential of our biotech ecosystem. Here's to science driving progress and transforming lives! Read more: https://lnkd.in/gCw8jFhP #Innovation #Startups #BiotechRevolution #BiotechIndia Rajesh Gokhale | Jitendra Kumar | DBT BIRAC | Department of Biotechnology

#BIRAC collaborated with Centre of Excellence Biopharmaceutical Technology, Indian Institute of Technology, Delhi, for the 9th edition of CBT Course Series 2024, an international lecture series on upstream, downstream, analytical, regulatory and data analytics aspects for biosimilars. The two-day regulatory module featured engaging deliberations on key concepts of regulatory approval for biopharmaceuticals, delivered by esteemed speakers from national and international government and industry bodies. Greg Smith, USFDA initiated the discussions with an overview of the FDA India Office and Future Engagement. Arvind Kukrety CDSCO presented an in-depth talk on India's Regulatory Landscape and Biosimilar Application Framework. Sonia Gandhi, BIRAC highlighted the need for innovations in the regulatory framework for biosimilars and identified gaps for potential improvement in regulatory framework. Vivek Tyagi explained the CCSEA's role in Regulatory Framework for Animal Experimentation in #India. Dr.Poonam Vishwakarma, Biosafety Unit-DBT presented the approval process for GMO research, including RCGM guidelines and BioRRAP standards. Industry veterans Narendra Chirmule, SymphonyTech Biologics , Dhananjay Patankar, Samir Sangitrao, Zydus Group, Cadila shared their extensive experience on Reference Product Selection, Quality Assessment, and Characterization, pre-clinical and clinical studies, including data requirements, PK, PD, toxicological studies, animal model selection, and study waivers. The international perspective on Harmonising Regulatory Pathways for mAbs was covered by Rajat Goyal, IAVI. P.S. Chandranand, PhD, C-CAMP shared the requirements for WHO-PQ standards for Biosimilars and Annu Uppal, US Pharmacopeia discussed the Regulatory and Analytical issues for Peptide Therapeutics. The event underscores BIRAC's commitment to enhancing biopharmaceutical #innovation and fostering worldwide regulatory #collaboration. Jitendra Kumar | Dr. Raj K Shirumalla | Sonia Gandhi | Anurag Rathore | Rozaleen Dash, PhD | Rashmi Rathour | Anandi Chowdhury Biotechnology Industry Research Assistance Council (BIRAC) | OPERON | IAVI | SymphonyTech Biologics | Zydus Cadila Healthcare Limited | Centre for Cellular and Molecular Platforms (C-CAMP) | US Pharmacopeia